Balyasny Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-57,078
Closed -$516K 2877
2023
Q1
$516K Buy
+57,078
New +$498K ﹤0.01% 1945
2020
Q4
Sell
-33,734
Closed -$1.57M 1777
2020
Q3
$1.57M Buy
+33,734
New +$1.16M 0.01% 900
2018
Q4
Sell
-82,500
Closed -$1.29M 1819
2018
Q3
$1.29M Buy
+82,500
New +$1.18M 0.01% 1107

Other funds holding ZYME

Balyasny Asset Management's ZYME Position: Q2 2023 in Review

Balyasny Asset Management sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 57,078 shares — an estimated $516K sold.

Balyasny Asset Management first reported a position in ZYME in Q3 2018 and held it in 3 quarters. The position peaked at $1.57M in Q3 2020. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • Balyasny Asset Management reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 57,078 Zymeworks shares in Q2 2023, an estimated $516K.
  • Balyasny Asset Management first reported a position in Zymeworks in Q3 2018 and held it in 3 quarters.
  • Balyasny Asset Management's Zymeworks position peaked at $1.57M in Q3 2020.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.